These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 33372534)

  • 1. Paroxetine Attenuates Cardiac Hypertrophy Via Blocking GRK2 and ADRB1 Interaction in Hypertension.
    Sun X; Zhou M; Wen G; Huang Y; Wu J; Peng L; Jiang W; Yuan H; Lu Y; Cai J
    J Am Heart Assoc; 2021 Jan; 10(1):e016364. PubMed ID: 33372534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective Effects of the GRK2 Inhibitor Paroxetine on Isoproterenol-Induced Cardiac Remodeling by Modulating NF-κB Mediated Prohypertrophic and Profibrotic Gene Expression.
    Alonazi AS; Bin Dayel AF; Albuaijan DA; Bin Osfur AS; Hakami FM; Alzayed SS; Almotairi AR; Khan MR; Alharbi HM; Ali RA; Alamin MA; Alghibiwi HK; Alrasheed NM; Alhosaini KA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.
    Schumacher SM; Gao E; Zhu W; Chen X; Chuprun JK; Feldman AM; Tesmer JJ; Koch WJ
    Sci Transl Med; 2015 Mar; 7(277):277ra31. PubMed ID: 25739765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRK2 participation in cardiac hypertrophy induced by isoproterenol through the regulation of Nrf2 signaling and the promotion of NLRP3 inflammasome and oxidative stress.
    Liu J; Li X; Ding L; Li W; Niu X; Gao D
    Int Immunopharmacol; 2023 Apr; 117():109957. PubMed ID: 37012864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.
    Piao L; Fang YH; Parikh KS; Ryan JJ; D'Souza KM; Theccanat T; Toth PT; Pogoriler J; Paul J; Blaxall BC; Akhter SA; Archer SL
    Circulation; 2012 Dec; 126(24):2859-69. PubMed ID: 23124027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein-coupled receptor kinase 2 promotes cardiac hypertrophy.
    Schlegel P; Reinkober J; Meinhardt E; Tscheschner H; Gao E; Schumacher SM; Yuan A; Backs J; Most P; Wieland T; Koch WJ; Katus HA; Raake PW
    PLoS One; 2017; 12(7):e0182110. PubMed ID: 28759639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxetine is a direct inhibitor of g protein-coupled receptor kinase 2 and increases myocardial contractility.
    Thal DM; Homan KT; Chen J; Wu EK; Hinkle PM; Huang ZM; Chuprun JK; Song J; Gao E; Cheung JY; Sklar LA; Koch WJ; Tesmer JJ
    ACS Chem Biol; 2012 Nov; 7(11):1830-9. PubMed ID: 22882301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Determinants Influencing the Potency and Selectivity of Indazole-Paroxetine Hybrid G Protein-Coupled Receptor Kinase 2 Inhibitors.
    Bouley R; Waldschmidt HV; Cato MC; Cannavo A; Song J; Cheung JY; Yao XQ; Koch WJ; Larsen SD; Tesmer JJG
    Mol Pharmacol; 2017 Dec; 92(6):707-717. PubMed ID: 29070696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin induces IRS2-dependent and GRK2-mediated β2AR internalization to attenuate βAR signaling in cardiomyocytes.
    Fu Q; Xu B; Parikh D; Cervantes D; Xiang YK
    Cell Signal; 2015 Mar; 27(3):707-15. PubMed ID: 25460042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificities of g protein-coupled receptor kinase-2 and -3 at cardiac myocyte receptors provide basis for distinct roles in regulation of myocardial function.
    Vinge LE; Andressen KW; Attramadal T; Andersen GØ; Ahmed MS; Peppel K; Koch WJ; Freedman NJ; Levy FO; Skomedal T; Osnes JB; Attramadal H
    Mol Pharmacol; 2007 Sep; 72(3):582-91. PubMed ID: 17573483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels.
    Lucas E; Vila-Bedmar R; Arcones AC; Cruces-Sande M; Cachofeiro V; Mayor F; Murga C
    Cardiovasc Diabetol; 2016 Nov; 15(1):155. PubMed ID: 27832814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of the G protein-coupled receptor kinase 2 and Rab5 in α
    Hernández-Espinosa DA; Reyes-Cruz G; García-Sáinz JA
    Eur J Pharmacol; 2020 Jan; 867():172846. PubMed ID: 31811856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction.
    Tian X; Wang Q; Guo R; Xu L; Chen QM; Hou Y
    Neuropsychiatr Dis Treat; 2016; 12():2333-2341. PubMed ID: 27695334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between ADRB1 and CYP2D6 gene polymorphisms and the response to β-blocker therapy in hypertension.
    Wu D; Li G; Deng M; Song W; Huang X; Guo X; Wu Z; Wu S; Xu J
    J Int Med Res; 2015 Jun; 43(3):424-34. PubMed ID: 25823457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach.
    Thomas KL; Ellingrod VL; Bishop JR; Keiser MJ
    Psychopharmacol Bull; 2010; 43(1):11-22. PubMed ID: 20581797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxetine mitigates cardiac remodelling by doxorubicin and increases survival.
    Kosić M; Nešić Z; Glumac S; Vasić M; Pajović V; Savić B; Japundžić-Žigon N
    Biomed Pharmacother; 2022 Jan; 145():112411. PubMed ID: 34781149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of paroxetine on proximal β-adrenergic receptor signaling.
    Guo S; Carter RL; Grisanti LA; Koch WJ; Tilley DG
    Cell Signal; 2017 Oct; 38():127-133. PubMed ID: 28711716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptide of the amino-terminus of GRK2 induces hypertrophy and yet elicits cardioprotection after pressure overload.
    Bledzka KM; Manaserh IH; Grondolsky J; Pfleger J; Roy R; Gao E; Chuprun JK; Koch WJ; Schumacher SM
    J Mol Cell Cardiol; 2021 May; 154():137-153. PubMed ID: 33548241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine.
    Waldschmidt HV; Homan KT; Cato MC; Cruz-Rodríguez O; Cannavo A; Wilson MW; Song J; Cheung JY; Koch WJ; Tesmer JJ; Larsen SD
    J Med Chem; 2017 Apr; 60(7):3052-3069. PubMed ID: 28323425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction.
    Lymperopoulos A; Rengo G; Gao E; Ebert SN; Dorn GW; Koch WJ
    J Biol Chem; 2010 May; 285(21):16378-86. PubMed ID: 20351116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.